2-Bromo-5-chlorobenzotrifluoride CAS:344-65-0

2-Bromo-5-chlorobenzotrifluoride

Chemical Name: 2-Bromo-5-chlorobenzotrifluoride
CAS.NO:344-65-0
Synonyms:1-Bromo-4-chloro-2-(trifluoromethyl)benzene;
1-bromo-4-chloro-2-trifluoromethyl-benzene;
1-Brom-4-chlor-2-trifluormethyl-benzol;
2-BROMO-5-CHOROBENZOTRIFLUORIDE;
Molecular Formula: C7H3BrClF3
Molecular Weight:259.45100
 
Physical and Chemical Properties:
Density:1.759 g/mL at 25 °C(lit.)
Melting point:18-20°C
Boiling point:179-180 °C(lit.)
Flash point:198°C
Index of Refraction:1.508
 
Specification:
Appearance:Colorless liquid
Purity:≥98.0%
 
Packing:25KG/Fiber Drum,
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:  Applicationd as dye, pharmaceutical, and pesticide intermediates



We are professional 2-Bromo-5-chlorobenzotrifluoride manufacturer and 2-BROMO-5-CHOROBENZOTRIFLUORIDE supplier in China, We offer quality 2-Bromo-5-chlorobenzotrifluoride you can fully trust, also we have India factory and producer of 2-BROMO-5-CHOROBENZOTRIFLUORIDE,Pls send inquiry of 2-Bromo-5-chlorobenzotrifluoride CAS:344-65-0 to info@nbinno.com if you have any interests, thank you!


Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.Methyl 2-bromopropionate CAS:5445-17-0 This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.tert-Butylisocyanate CAS:1609-86-5 At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.4-Bromobenzaldehyde The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.